This compound is a bicyclic nucleoside analog, specifically a derivative of guanosine, characterized by the presence of a methylene bridge between the 2'-oxygen and 4'-carbon atoms of the ribose sugar. It serves as a pharmaceutical intermediate for the synthesis of nucleoside analogs.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 207131-16-6
((2R,3S,5R)-5-(6-Amino-9H-purin-9-yl)-3-hydroxytetrahydrofuran-2-yl)methyl 4-methylbenzenesulfonate
pharmaceutical intermediate for nucleoside analogs
2'-Deoxy-2'-fluoroguanosine
pharmaceutical intermediate for nucleoside analogs
2-deoxy-2,2-difluoro-d-erythro-pentofuranose-3,5-dibenzoate-1-methanesulfonate
pharmaceutical intermediate for nucleoside analogs
Fmoc-Ala-OH H2O
Fmoc-protected amino acid for peptide synthesis
4-(Cbz-amino)piperidine Hydrochloride
Pharmaceutical intermediate
(2S)-4-[[(TERT-BUTOXY)CARBONYL]AMINO]-2-HYDROXYBUTANOIC ACID
Boc-protected amino acid intermediate
1,8-Bis(dimethylamino)naphthalene
Proton sponge for organic synthesis
2-amino-9-[(1S,3R,4R,7S)-7-hydroxy-1-(hydroxymethyl)-2,5-dioxabicyclo[2.2.1]heptan-3-yl]-1H-purin-6-one
OZVMOEUWPMYRQU-JUQFDLSGSA-N
C1[C@]2([C@H]([C@@H](O1)[C@@H](O2)N3C=NC4=C3N=C(NC4=O)N)O)CO